Assessment and prevention of exercise-induced bronchoconstriction

British Journal of Sports Medicine

Volumn 46, Issue 6, 2012, Pages 391-396

  Anderson, Sandra D ^a   Kippelen, Pascale ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHOCONSTRICTING AGENT; DIAGNOSTIC AGENT; HISTAMINE; MANNITOL; METHACHOLINE CHLORIDE; OSMOTIC DIURETIC AGENT; SODIUM CHLORIDE;

BRONCHOSPASM; BRONCHUS DISEASE; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERVENTILATION; INHALATION TEST; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STENOSIS, OCCLUSION AND OBSTRUCTION;

BRONCHIAL DISEASES; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; CONSTRICTION, PATHOLOGIC; DIURETICS, OSMOTIC; EXERCISE; FORCED EXPIRATORY VOLUME; HISTAMINE; HUMANS; HYPERVENTILATION; MANNITOL; METHACHOLINE CHLORIDE; SALINE SOLUTION, HYPERTONIC;

EID: 84860175606     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2011-090810     Document Type: Review

References (65)

1. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is. J Allergy Clin Immunol 2000;106:453-9.
2. Anderson SD. Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010;138:25S-30S.
3. Rundell KW, Im J, Mayers LB, et al. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc 2001;33:208-13. (Pubitemid 32142984)
4. Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes: Challenges for diagnosis. J Allergy Clin Immunol 2002;110:374-80.
5. Sue-Chu M, Brannan JD, Anderson SD, et al. Airway hyperresponsiveness to methacholine, adenosine 5-monophosphate, mannitol, eucapnic voluntary hyperpnoea and field exercise challenge in elite cross-country skiers. Br J Sports Med 2010;44:827-32.
6. Dickinson J, McConnell A, Whyte G. Diagnosis of exercise-induced bronchoconstriction: eucapnic voluntary hyperpnoea challenges identify previously undiagnosed elite athletes with exercise-induced bronchoconstriction. Br J Sports Med 2011;45:1126-31.
7. Dickinson JW, Whyte G P, McConnell AK, et al. Screening elite winter athletes for exercise induced asthma: a comparison of three challenge methods. Br J Sports Med 2006;40:179-82. (Pubitemid 43362468)
8. Rundell KW, Wilber RL, Szmedra L, et al. Exercise-induced asthma screening of elite athletes: field versus laboratory exercise challenge. Med Sci Sports Exerc 2000;32:309-16. (Pubitemid 30108109)
9. Anderson SD, Argyros GJ, Magnussen H, et al. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med 2001;35:344-7. (Pubitemid 32929823)
10. Brannan JD, Anderson SD, Perry CP, et al.; Aridol Study Group. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 2005;6:144.
11. Holzer K, Anderson SD, Chan HK, et al. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003;167:534-7.
12. Anderson SD, Charlton B, Weiler JM, et al.; A305 Study Group. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res 2009;10:4.
13. Anderson SD, Pearlman DS, Rundell KW, et al. Reproducibility of the airway response to an exercise protocol standardized for intensity, duration, and inspired air conditions, in subjects with symptoms suggestive of asthma. Respir Res 2010;11:120.
14. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-29.
15. Rundell KW, Anderson SD, Spiering BA, et al. Field exercise vs laboratory eucapnic voluntary hyperventilation to identify airway hyperresponsiveness in elite cold weather athletes. Chest 2004;125:909-15. (Pubitemid 38367281)
16. Argyros GJ, Roach JM, Hurwitz KM, et al. Eucapnic voluntary hyperventilation as a bronchoprovocation technique: development of a standarized dosing schedule in asthmatics. Chest 1996;109:1520-4. (Pubitemid 26193378)
17. Spiering BA, Judelson DA, Rundell KW. An evaluation of standardizing target ventilation for eucapnic voluntary hyperventilation using FEV1. J Asthma 2004;41:745-9. (Pubitemid 39546320)
18. Brummel NE, Mastronarde JG, Rittinger D, et al. The clinical utility of eucapnic voluntary hyperventilation testing for the diagnosis of exercise-induced bronchospasm. J Asthma 2009;46:683-6.
19. Kippelen P, Larsson J, Anderson SD, et al. Effect of sodium cromoglycate on mast cell mediators during hyperpnea in athletes. Med Sci Sports Exerc 2010;42:1853-60.
20. Kippelen P, Larsson J, Anderson SD, et al. Acute effects of beclomethasone on hyperpnea-induced bronchoconstriction. Med Sci Sports Exerc 2010;42:273-80.
21. Brannan JD, Gulliksson M, Anderson SD, et al. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J 2006;27:944-50. (Pubitemid 44911107)
22. Larsson J, Perry C P, Anderson SD, et al. The occurrence of refractoriness and mast cell mediator release following mannitol-induced bronchoconstriction. J Appl Physiol 2011;110:1029-35.
23. Brannan JD, Koskela H, Anderson SD, et al. Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med 1998;158:1120-6. (Pubitemid 28489011)
24. Smith CM, Anderson SD. Inhalational challenge using hypertonic saline in asthmatic subjects: a comparison with responses to hyperpnoea, methacholine and water. Eur Respir J 1990;3:144-51. (Pubitemid 20066914)
25. Anderson SD, Brannan JD. Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Clin Rev Allergy Immunol 2003;24:63-90.
26. Riedler J, Reade T, Dalton M, et al. Hypertonic saline challenge in an epidemiologic survey of asthma in children. Am J Respir Crit Care Med 1994;150:1632-9. (Pubitemid 24361739)
27. Anderson SD, Kippelen P. Exercise-induced bronchoconstriction: pathogenesis. Curr Allergy Asthma Rep 2005;5:116-22. (Pubitemid 40331067)
28. Sue-Chu M, Karjalainen EM, Laitinen A, et al. Placebo-controlled study of inhaled budesonide on indices of airway inflammation in bronchoalveolar lavage fl uid and bronchial biopsies in cross-country skiers. Respiration 2000;67:417-25. (Pubitemid 30666005)
29. Stadelmann K, Stensrud T, Carlsen KH. Respiratory symptoms and bronchial responsiveness in competitive swimmers. Med Sci Sports Exerc 2011;43:375-81.
30. Pedersen L, Winther S, Backer V, et al. Airway responses to eucapnic hyperpnea, exercise, and methacholine in elite swimmers. Med Sci Sports Exerc 2008;40:1567-72.
31. Norval J, Perry CP, Anderson SD. Responses to methacholine and eucapnic voluntary hyperpnea in relation to baseline lung function [abstract]. Respirology 2007;12:A1.
32. Stickland MK, Rowe BH, Spooner CH, et al. Accuracy of eucapnic hyperpnea or mannitol to diagnose exercise-induced bronchoconstriction: a systematic review. Ann Allergy Asthma Immunol 2011;107:229-34.e8.
33. Boulet LP. Cough and upper airways disorders in athletes: mechanisms and prevention. Brit J Sports Med 2012;46:417-21.
34. Rundell KW, Spiering BA. Inspiratory stridor in elite athletes. Chest 2003;123:468-74. (Pubitemid 36269432)
35. Helenius IJ, Tikkanen HO, Haahtela T. Occurrence of exercise induced bronchospasm in elite runners: dependence on atopy and exposure to cold air and pollen. Br J Sports Med 1998;32:125-9. (Pubitemid 28271446)
36. Bougault V, Turmel J, Boulet LP. Airway hyperresponsiveness in elite swimmers: is it a transient phenomenon? J Allergy Clin Immunol 2011;127:892-8.
37. Subbarao P, Duong M, Adelroth E, et al. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol 2006;117:1008-13.
38. Duong M, Subbarao P, Adelroth E, et al. Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest 2008;133:404-11. (Pubitemid 351272398)
39. Anderson SD, Schoeffel RE, Follet R, et al. Sensitivity to heat and water loss at rest and during exercise in asthmatic patients. Eur J Respir Dis 1982;63:459-71. (Pubitemid 12029106)
40. Anderson SD, Schoeffel RE, Black JL, et al. Airway cooling as the stimulus to exercise-induced asthma-a re-evaluation. Eur J Respir Dis 1985;67:20-30. (Pubitemid 15227382)
41. Dougherty RH, Sidhu SS, Raman K, et al. Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol 2010;125:1046-53.e8.
42. O'Sullivan S, Roquet A, Dahlén B, et al. Evidence for mast cell activation during exercise-induced bronchoconstriction. Eur Respir J 1998;12:345-50. (Pubitemid 28389527)
43. Reiss TF, Hill JB, Harman E, et al. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:1030-5. (Pubitemid 27515780)
44. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-52. (Pubitemid 28328478)
45. Brannan JD, Anderson SD, Gomes K, et al. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol. Am J Respir Crit Care Med 2001;163:1420-5. (Pubitemid 32506610)
46. Brannan JD, Gulliksson M, Anderson SD, et al. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J 2003;22:491-6. (Pubitemid 37098931)
47. Kersten ET, Driessen JM, van Leeuwen JC, et al. Pilot study: The effect of reducing treatment on exercise induced bronchoconstriction. Pediatr Pulmonol 2010;45:927-33.
48. Anderson SD, Caillaud C, Brannan JD. Beta2-agonists and exercise-induced asthma. Clin Rev Allergy Immunol 2006;31:163-80.
49. Haney S, Hancox RJ. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med 2005;99:566-71. (Pubitemid 40468503)
50. Ramage L, Lipworth BJ, Ingram CG, et al. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol. Respir Med 1994;88:363-8. (Pubitemid 24167105)
51. Edelman JM, Turpin JA, Bronsky EA, et al. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Ann Intern Med 2000;132:97-104. (Pubitemid 30044175)
52. Hancox RJ, Subbarao P, Kamada D, et al. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 2002;165:1068-70.
53. Haney S, Hancox RJ. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 2006;31:181-96. (Pubitemid 44804947)
54. Simons FE, Gerstner T V, Cheang MS. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment. Pediatrics 1997;99:655-9. (Pubitemid 27193764)
55. Scola AM, Chong LK, Suvarna SK, et al. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmacol 2004;141:163-71. (Pubitemid 38241174)
56. Spooner CH, Spooner GR, Rowe BH. Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction. Cochrane Database Syst Rev 2003;4:CD002307.
57. Hallstrand TS, Moody MW, Wurfel MM, et al. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2005;172:679-86. (Pubitemid 41324221)
58. Mickleborough TD, Murray RL, Ionescu AA, et al. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003;168:1181-9. (Pubitemid 37421835)
59. WADA. World Anti Doping Authority: Prohibited List, http://wada-ama.org/ en/Science-Medicine/Prohibited-List/The-2011-Prohibited-List/ (accessed 19 November 2011).
60. Reiff DB, Choudry NB, Pride NB, et al. The effect of prolonged submaximal warm-up exercise on exercise-induced asthma. Am Rev Respir Dis 1989;139:479-84. (Pubitemid 19057429)
61. Mickleborough TD, Lindley MR, Turner LA. Comparative effects of a high-intensity interval warm-up and salbutamol on the bronchoconstrictor response to exercise in asthmatic athletes. Int J Sports Med 2007;28:456-62. (Pubitemid 46953747)
62. Schoeffel RE, Anderson SD, Gillam I, et al. Multiple exercise and histamine challenge in asthmatic patients. Thorax 1980;35:164-70. (Pubitemid 10131194)
63. Manning PJ, Watson RM, O'Byrne PM. Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms. Am Rev Respir Dis 1993;148:950-4. (Pubitemid 23301212)
64. Mangla PK, Menon M P. Effect of nasal and oral breathing on exercise-induced asthma. Clin Allergy 1981;11:433-9. (Pubitemid 12235047)
65. Millqvist E, Bengtsson U, Löwhagen O. Combining a beta2-agonist with a face mask to prevent exercise-induced bronchoconstriction. Allergy 2000;55:672-5. (Pubitemid 30439003)